Trial
NCT04452006
A Study in Healthy Subjects to Investigate the Safety and Tolerability of ACT- 541478 as Well as What ACT-541478 Does to the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-541478
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Idorsia Pharmaceuticals Ltd.
Collaborators
—
Condition
Healthy
Intervention
ACT-541478 10 mg
Why stopped
Based on interim analysis, the Sponsor decided to terminate the study prematurely.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-07-09